Warning Letter — Psyched Wellness Ltd.
The FDA issued a warning letter to Psyched Wellness Ltd. following an evaluation by the Human Foods Program regarding the regulatory status and labeling of their products.
This affects Psyched Wellness Ltd., its regulatory and compliance departments, and manufacturers or distributors of similar functional food or supplement products making health-related claims.
This enforcement action indicates that the FDA is actively monitoring the functional food and psychedelic-adjacent market for products that may be marketed with unapproved therapeutic claims. It suggests that companies in this sector must strictly adhere to food labeling requirements to avoid being classified and regulated as unapproved new drugs.
Regulatory teams should conduct a thorough audit of all digital marketing collateral, including social media and third-party links, to ensure no therapeutic claims are being made. Review product classifications to confirm that ingredients and intended uses do not inadvertently trigger drug status under FDA regulations.
FDA Warning Letter issued to: Psyched Wellness Ltd.. 09/29/2026 — Human Foods Program. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/psyched-wellness-ltd-730137-09292026
Open in openFDA / FDA.gov